Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Clinics in Chest Medicine
|
November 17, 2019
Treatment of Drug-Susceptible Tuberculosis
Beth Shoshana Zha, Payam Nahid
Research Square
|
July 3, 2023
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
Weihao Zheng, I-Chang Chang, Jason Limberis, et al.
Plos Pathogens
|
May 3, 2024
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
Weihao Zheng, I-Chang Chang, Jason Limberis, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
How Mycobacterium tuberculosis builds a home: Single-cell analysis reveals M. tuberculosis ESX-1-mediated accumulation of anti-inflammatory macrophages in infected mouse lungs
Weihao Zheng, Michael Borja, Leah Dorman, et al.
Science Advances
|
January 15, 2025
Single-cell analysis reveals <i>Mycobacterium tuberculosis</i> ESX-1-mediated accumulation of permissive macrophages in infected mouse lungs
Weihao Zheng, Michael Borja, Leah C Dorman, et al.
Nature Chemical Biology
|
October 21, 2020
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Biorxiv : the Preprint Server for Biology
|
August 21, 2020
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Nature Communications
|
October 6, 2023
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sara Sunshine, Andreas S Puschnik, Joseph M Replogle, et al.
Nature Communications
|
October 30, 2024
Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia
Natasha Spottiswoode, Alexandra Tsitsiklis, Victoria T Chu, et al.
Research Square
|
January 20, 2021
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone
Aartik Sarma, Stephanie A Christenson, Eran Mick, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Clinics in Chest Medicine
|
November 17, 2019
Treatment of Drug-Susceptible Tuberculosis
Beth Shoshana Zha, Payam Nahid
Research Square
|
July 3, 2023
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
Weihao Zheng, I-Chang Chang, Jason Limberis, et al.
Plos Pathogens
|
May 3, 2024
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection
Weihao Zheng, I-Chang Chang, Jason Limberis, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
How Mycobacterium tuberculosis builds a home: Single-cell analysis reveals M. tuberculosis ESX-1-mediated accumulation of anti-inflammatory macrophages in infected mouse lungs
Weihao Zheng, Michael Borja, Leah Dorman, et al.
Science Advances
|
January 15, 2025
Single-cell analysis reveals <i>Mycobacterium tuberculosis</i> ESX-1-mediated accumulation of permissive macrophages in infected mouse lungs
Weihao Zheng, Michael Borja, Leah C Dorman, et al.
Nature Chemical Biology
|
October 21, 2020
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2
Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Biorxiv : the Preprint Server for Biology
|
August 21, 2020
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
Colton J Bracken, Shion A Lim, Paige Solomon, et al.
Nature Communications
|
October 6, 2023
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sara Sunshine, Andreas S Puschnik, Joseph M Replogle, et al.
Nature Communications
|
October 30, 2024
Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia
Natasha Spottiswoode, Alexandra Tsitsiklis, Victoria T Chu, et al.
Research Square
|
January 20, 2021
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone
Aartik Sarma, Stephanie A Christenson, Eran Mick, et al.
Page
of 2